Cwm, LLC Arvinas, Inc. Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Cwm, LLC holds 7,615 shares of ARVN stock, worth $73,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,615

Previous 315 2317.46%

Holding current value

$73,256

Previous $6,000 783.33%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$7.02 - $20.5 $51,246 - $149,650	7,300 Added 2317.46%	7,615 $53,000
Q4 2024 Feb 04, 2025	BUY	$17.83 - $28.04 $2,103 - $3,308	118 Added 59.9%	315 $6,000
Q3 2024 Oct 08, 2024	SELL	$23.66 - $32.73 $1,135 - $1,571	-48 Reduced 19.59%	197 $5,000
Q2 2024 Jul 09, 2024	BUY	$24.46 - $40.4 $2,494 - $4,120	102 Added 71.33%	245 $7,000
Q4 2023 Feb 01, 2024	SELL	$14.19 - $42.33 $9,322 - $27,810	-657 Reduced 82.13%	143 $6,000
Q3 2023 Oct 11, 2023	BUY	$19.64 - $28.21 $569 - $818	29 Added 3.76%	800 $16,000
Q2 2023 Aug 03, 2023	BUY	$21.73 - $31.43 $7,540 - $10,906	347 Added 81.84%	771 $19,000
Q1 2023 Apr 28, 2023	BUY	$26.15 - $37.26 $5,700 - $8,122	218 Added 105.83%	424 $12,000
Q4 2022 Feb 01, 2023	SELL	$32.47 - $57.24 $7,338 - $12,936	-226 Reduced 52.31%	206 $7,000
Q3 2022 Oct 27, 2022	BUY	$41.87 - $57.99 $1,046 - $1,449	25 Added 6.14%	432 $19,000
Q2 2022 Jul 28, 2022	BUY	$36.01 - $74.24 $5,365 - $11,061	149 Added 57.75%	407 $17,000
Q1 2022 Apr 21, 2022	BUY	$60.27 - $81.57 $2,229 - $3,018	37 Added 16.74%	258 $17,000
Q1 2021 Sep 15, 2021	BUY	$58.19 - $91.37 $12,859 - $20,192	221 New	221 $17,000
Q1 2021 Apr 27, 2021	SELL	$58.19 - $91.37 $12,859 - $20,192	-221 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$20.19 - $84.93 $4,461 - $18,769	221 New	221 $17,000
Q4 2020 Jan 27, 2021	SELL	$20.19 - $84.93 $4,461 - $18,769	-221 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$22.99 - $36.34 $5,080 - $8,031	221 New	221 $17,000
Q3 2020 Oct 19, 2020	SELL	$22.99 - $36.34 $5,080 - $8,031	-221 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$29.88 - $56.74 $6,603 - $12,539	221 New	221 $17,000
Q2 2020 Jul 22, 2020	SELL	$29.88 - $56.74 $6,603 - $12,539	-221 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$33.0 - $54.5 $7,293 - $12,044	221 New	221 $17,000
Q1 2020 Apr 28, 2020	SELL	$33.0 - $54.5 $7,293 - $12,044	-221 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$15.39 - $44.38 $3,401 - $9,807	221 New	221 $17,000
Q4 2019 Jan 27, 2020	SELL	$15.39 - $44.38 $3,401 - $9,807	-221 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$21.55 - $27.61 $4,762 - $6,101	221 New	221 $17,000
Q3 2019 Oct 22, 2019	SELL	$21.55 - $27.61 $4,762 - $6,101	-221 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$15.96 - $23.8 $3,527 - $5,259	221 New	221 $17,000
Q2 2019 Jul 31, 2019	SELL	$15.96 - $23.8 $3,527 - $5,259	-221 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$13.55 - $23.79 $2,994 - $5,257	221 New	221 $0

Others Institutions Holding ARVN

# of Institutions

223

Shares Held

70.8M

Call Options Held

1.52M

Put Options Held

346K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $512M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account